Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-003040
Filing Date
2023-02-09
Accepted
2023-02-09 19:52:54
Documents
2
Period of Report
2023-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167599036026189.html 3  
1 FORM 3 wf-form3_167599036026189.xml 3 1710
2 TAKESHI TAKAHASHI POA ex-24.htm EX-24 4831
  Complete submission text file 0001628280-23-003040.txt   7977
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERALYS THERAPEUTICS, INC. 150 N. RADNOR CHESTER RD, STE. F200 RADNOR PA 19087
Business Address
Takahashi Takeshi (Reporting) CIK: 0001963933 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41614 | Film No.: 23608036